An interventional study of Slider Neurodynamic Technique Group and Tensioner Neurodynamic Technique Group in Sciatica and Sciatica Pain, sponsored by Ibadat International University, Islamabad. Recruiting at 1 site in Pakistan. Open to participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-06-08.
Sponsored by Ibadat International University, Islamabad · Not applicable, Interventional, and Treatment
objective of this randomized controlled trial is to examine the efficacy of both tensioner and slider neurodynamic approaches in patients suffering from sciatica. This study seeks to establish which approach is more efficacious in alleviating pain intensity, disability functional, and mobility. The results of this study will assist physical therapists in making an informed decision on the type of neurodynamic therapy for their patients.
Due to the increasing prevalence of sciatica and evidence based treatment options using physiotherapy that offers effective alleviation of pain and rehabilitation of function. Neurodynamic mobilization focuses on addressing neurological problems; thus, there is a need to know about the effectiveness of the different types of the technique being used.
The current research is expected to contribute to the existing literature in the area of physiotherapy concerning the identification of the most effective neurodynamic technique in the case of sciatica. These findings could be helpful for medical practitioners during their work, making decisions and planning treatment. At the same time, the results of the investigation may become the basis for further research.
149 studies on the registry are indexed under Sciatica; 31 are open to participants now.
This study's planned enrollment of 80 is above the median of 68 across 122 interventional studies indexed under Sciatica.
Browse Sciatica studies →Ibadat International University, Islamabad is the lead sponsor of 53 studies on the registry; 36 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive slider neurodynamic mobilization techniques along with conventional physiotherapy management.
Other: Slider Neurodynamic Technique Group
Participants will receive tensioner neurodynamic mobilization techniques along with conventional physiotherapy management.
Other: Tensioner Neurodynamic Technique Group
will receive slider neurodynamic mobilization techniques along with conventional physiotherapy management.
will receive tensioner neurodynamic mobilization techniques along with conventional physiotherapy management.
Pain intensity
will be measured using VAS
Time frame: Baseline to Week 8
Functional disability
measured using Oswestry Disability Index (ODI)
Time frame: Baseline to week 8
Hip range of motion
assessed using Goniometer
Time frame: Baseline to week 8
Lumbar flexion Range of Motion
measured using Modified-Modified Schober Test (MMST)
Time frame: Baseline to Week 8
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ibadat International University, Islamabad